US EditionPublished • loading... • Updated
GOP-led states challenging FDA approval of generic abortion pill
Missouri AG challenges FDA approval citing safety and regulatory concerns while opposing expanded access to generic mifepristone, amid a legal push also involving Idaho and Kansas.
- Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the FDA's recent decision to approve a new generic brand of mifepristone, a drug used for medication abortion.
- The lawsuit demands restoring previous restrictions on mifepristone, including requiring three in-person doctor visits, reducing the gestational period from 10 weeks to seven, and rolling back the mailing of the drug.
- The FDA has reported only 32 deaths associated with mifepristone out of 5.9 million women who took it between 2000 and 2022.
Insights by Ground AI
9 Articles
9 Articles
Missouri challenges FDA approval of new generic mifepristone in push to limit abortion
Missouri is among three states challenging current federal regulations around mifepristone, a medication used to induce an abortion (Natalie Behring/Getty Images).Missouri Attorney General Catherine Hanaway is asking a federal court to roll back the U.S. Food and Drug Administration’s recent decision to approve a new generic brand of mifepristone, her first foray into a lawsuit filed by her predecessor to limit access to medication abortion nati…
·St. Louis, United States
Read Full Article
·New York, United States
Read Full ArticleCoverage Details
Total News Sources9
Leaning Left2Leaning Right2Center3Last UpdatedBias Distribution43% Center
Bias Distribution
- 43% of the sources are Center
43% Center
L 29%
C 43%
R 28%
Factuality
To view factuality data please Upgrade to Premium
